AIA
GILD icon

AIMZ Investment Advisors’s Gilead Sciences GILD Stock Holding History

AIMZ Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.55M Sell
61,338
-2,499
-4% -$350K 2.64% 7
2025
Q4 		$7.84M Sell
63,837
-293
-0.5% -$35.6K 2.24% 8
2025
Q3 		$7.12M Sell
64,130
-890
-1% -$101K 2.23% 8
2025
Q2 		$7.21M Sell
65,020
-1,456
-2% -$155K 2.41% 8
2025
Q1 		$7.45M Sell
66,476
-515
-0.8% -$53.1K 2.6% 7
2024
Q4 		$6.19M Sell
66,991
-489
-0.7% -$44K 2.15% 11
2024
Q3 		$5.66M Sell
67,480
-383
-0.6% -$29.2K 1.93% 12
2024
Q2 		$4.66M Sell
67,863
-536
-0.8% -$35.8K 1.67% 14
2024
Q1 		$5.01M Sell
68,399
-1,037
-1% -$79.7K 1.87% 13
2023
Q4 		$5.62M Sell
69,436
-1,038
-1% -$80.8K 2.28% 9
2023
Q3 		$5.28M Sell
70,474
-263
-0.4% -$20.2K 2.35% 9
2023
Q2 		$5.45M Sell
70,737
-337
-0.5% -$26.9K 2.34% 7
2023
Q1 		$5.9M Sell
71,074
-1,119
-2% -$92.7K 2.64% 7
2022
Q4 		$6.2M Sell
72,193
-1,240
-2% -$98.2K 2.93% 6
2022
Q3 		$4.53M Sell
73,433
-576
-0.8% -$36.3K 2.29% 9
2022
Q2 		$4.57M Sell
74,009
-236
-0.3% -$14.6K 2.19% 10
2022
Q1 		$4.41M Buy
74,245
+4,214
+6% +$269K 1.81% 12
2021
Q4 		$5.08M Buy
70,031
+1,262
+2% +$86.9K 1.98% 11
2021
Q3 		$4.8M Buy
68,769
+306
+0.4% +$21.5K 2.17% 10
2021
Q2 		$4.71M Buy
68,463
+37
+0.1% +$2.47K 2.11% 11
2021
Q1 		$4.42M Sell
68,426
-152
-0.2% -$9.8K 2.16% 12
2020
Q4 		$4M Buy
68,578
+11,420
+20% +$689K 2.09% 12
2020
Q3 		$3.61M Sell
57,158
-524
-0.9% -$36.3K 2.16% 11
2020
Q2 		$4.44M Buy
57,682
+487
+0.9% +$37.3K 2.88% 6
2020
Q1 		$4.28M Buy
57,195
+3,863
+7% +$267K 3.32% 4
2019
Q4 		$3.46M Sell
53,332
-147
-0.3% -$9.57K 2.24% 12
2019
Q3 		$3.39M Sell
53,479
-636
-1% -$41.6K 2.33% 11
2019
Q2 		$3.66M Buy
54,115
+13
+0% +$855 2.52% 9
2019
Q1 		$3.52M Buy
54,102
+364
+0.7% +$24.2K 2.41% 11
2018
Q4 		$3.36M Buy
53,738
+15,333
+40% +$1.07M 2.6% 10
2018
Q3 		$2.96M Buy
38,405
+248
+0.6% +$18.7K 1.91% 17
2018
Q2 		$2.7M Sell
38,157
-281
-0.7% -$19.8K 1.91% 16
2018
Q1 		$2.9M Buy
38,438
+178
+0.5% +$14.2K 2.1% 15
2017
Q4 		$2.74M Sell
38,260
-302
-0.8% -$22.9K 2.06% 14
2017
Q3 		$3.12M Sell
38,562
-128
-0.3% -$9.79K 2.56% 9
2017
Q2 		$2.74M Sell
38,690
-467
-1% -$31.1K 2.3% 14
2017
Q1 		$2.66M Sell
39,157
-242
-0.6% -$17K 2.24% 13
2016
Q4 		$2.82M Sell
39,399
-177
-0.4% -$13.2K 2.52% 8
2016
Q3 		$3.13M Buy
39,576
+24,976
+171% +$2.03M 2.8% 6
2016
Q2 		$1.22M Buy
+14,600
New +$1.3M 1.12% 38
2016
Q1 		– Sell
-2,000
Closed -$202K – 107
2015
Q4 		$202K Buy
+2,000
New +$208K 0.18% 93
2015
Q3 		– Sell
-1,850
Closed -$217K – 95
2015
Q2 		$217K Buy
+1,850
New +$202K 0.19% 90

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AIMZ Investment Advisors's GILD Position: Q1 2026 in Review

AIMZ Investment Advisors reduced its Gilead Sciences (GILD) stake by 3.9% in Q1 2026, selling an estimated $350K and leaving 61,338 shares worth $8.55M. The position accounts for 2.64% of the portfolio, ranked #7.

AIMZ Investment Advisors first reported a position in GILD in Q2 2015 and has held it in 42 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • AIMZ Investment Advisors held 61,338 shares of Gilead Sciences worth $8.55M as of Q1 2026.
  • AIMZ Investment Advisors sold 2,499 Gilead Sciences shares in Q1 2026, an estimated $350K.
  • Gilead Sciences made up 2.64% of AIMZ Investment Advisors's portfolio in Q1 2026, its #7 holding.
  • AIMZ Investment Advisors first reported a position in Gilead Sciences in Q2 2015 and has held it in 42 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AIMZ Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.